Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastoma

BACKGROUND: The purpose of this study was to evaluate amifostine for protection from cisplatin-induced serious hearing loss in patients with average-risk medulloblastoma by extending a previous analysis to a much larger sample size. In addition, this study aimed to assess amifostine with serious hea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gurney, James G., Bass, Johnnie K., Onar-Thomas, Arzu, Huang, Jie, Chintagumpala, Murali, Bouffet, Eric, Hassall, Tim, Gururangan, Sridharan, Heath, John A., Kellie, Stewart, Cohn, Richard, Fisher, Michael J., Panandiker, Atmaram Pai, Merchant, Thomas E., Srinivasan, Ashok, Wetmore, Cynthia, Qaddoumi, Ibrahim, Stewart, Clinton F., Armstrong, Gregory T., Broniscer, Alberto, Gajjar, Amar
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
Pediatric Neuro-Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4022215/
https://ncbi.nlm.nih.gov/pubmed/24414535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/not241
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados